These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10196682)

  • 1. Granulomatous 'foreign body reactions' contribute to exaggerated in-stent restenosis.
    Kornowski R; Hong MK; Virmani R; Jones R; Vodovotz Y; Leon MB
    Coron Artery Dis; 1999; 10(1):9-14. PubMed ID: 10196682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis.
    Yutani C; Ishibashi-Ueda H; Suzuki T; Kojima A
    Cardiology; 1999; 92(3):171-7. PubMed ID: 10754347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of uncontrolled hyperglycemia on thrombosis and formation of neointima after coronary stent placement in a novel diabetic porcine model of restenosis.
    Carter AJ; Bailey L; Devries J; Hubbard B
    Coron Artery Dis; 2000 Sep; 11(6):473-9. PubMed ID: 10966133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study.
    Carter AJ; Laird JR; Bailey LR; Hoopes TG; Farb A; Fischell DR; Fischell RE; Fischell TA; Virmani R
    Circulation; 1996 Nov; 94(10):2364-8. PubMed ID: 8921774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saline infusion via local drug delivery catheters is associated with increased neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Kim WH; Hong MK; Kornowski R; Tio FO; Leon MB
    Coron Artery Dis; 1999 Dec; 10(8):629-32. PubMed ID: 10599542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model.
    Carter AJ; Laird JR; Farb A; Kufs W; Wortham DC; Virmani R
    J Am Coll Cardiol; 1994 Nov; 24(5):1398-405. PubMed ID: 7930266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.
    Holmes DR; Camrud AR; Jorgenson MA; Edwards WD; Schwartz RS
    J Am Coll Cardiol; 1994 Aug; 24(2):525-31. PubMed ID: 8034892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK; Kornowski R; Bramwell O; Ragheb AO; Leon MB
    Coron Artery Dis; 2001 Sep; 12(6):513-5. PubMed ID: 11696691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries.
    Matsumoto Y; Shimokawa H; Morishige K; Eto Y; Takeshita A
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):513-22. PubMed ID: 11904525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.
    Suzuki T; Kopia G; Hayashi S; Bailey LR; Llanos G; Wilensky R; Klugherz BD; Papandreou G; Narayan P; Leon MB; Yeung AC; Tio F; Tsao PS; Falotico R; Carter AJ
    Circulation; 2001 Sep; 104(10):1188-93. PubMed ID: 11535578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer stent coating for prevention of neointimal hyperplasia.
    Billinger M; Buddeberg F; Hubbell JA; Elbert DL; Schaffner T; Mettler D; Windecker S; Meier B; Hess OM
    J Invasive Cardiol; 2006 Sep; 18(9):423-6; discussion 427. PubMed ID: 16954581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent.
    Strehblow C; Sperker W; Hevesi A; Garamvölgyi R; Petrasi Z; Shirazi M; Sylvén C; Weiss T; Lotan C; Pugatsch T; Ben-Sasson SA; Orlowski M; Glogar D; Gyöngyösi M
    J Endovasc Ther; 2006 Feb; 13(1):94-103. PubMed ID: 16445329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.
    Huang Y; Salu K; Liu X; Li S; Wang L; Verbeken E; Bosmans J; De Scheerder I
    Heart; 2004 Feb; 90(2):195-9. PubMed ID: 14729797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK; Kent KM; Mehran R; Mintz GS; Tio FO; Foegh M; Wong SC; Cathapermal SS; Leon MB
    Circulation; 1997 Jan; 95(2):449-54. PubMed ID: 9008463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
    Banai S; Gertz SD; Gavish L; Chorny M; Perez LS; Lazarovichi G; Ianculuvich M; Hoffmann M; Orlowski M; Golomb G; Levitzki A
    Cardiovasc Res; 2004 Oct; 64(1):165-71. PubMed ID: 15364624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pathology: radiation-induced coronary artery disease in man and animals.
    Virmani R; Farb A; Carter AJ; Jones RM
    Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
    Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
    Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.
    Heldman AW; Cheng L; Jenkins GM; Heller PF; Kim DW; Ware M; Nater C; Hruban RH; Rezai B; Abella BS; Bunge KE; Kinsella JL; Sollott SJ; Lakatta EG; Brinker JA; Hunter WL; Froehlich JP
    Circulation; 2001 May; 103(18):2289-95. PubMed ID: 11342479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.